Molecular Imaging with MRI: Potential Application in Pancreatic Cancer

Figure 1

As PC progresses from PanINs to PDAC, each stage is well characterized by multiple molecular alternations. However, the identification of specific lesions using unique molecular markers as early as possible through molecular imaging will lead to the early detection of this deadly disease. The right illustrates the target materials that correspond to different PC biomarkers.